2025
SJR Q2
JCR Q3 · 2,1
8 matched articles
SCIE
Journal detail
Familial Cancer
- Publisher
- Springer Science and Business Media B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
1389960015737292
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,849
- Quartile Q2
- H-Index 72
- Cites/doc 2,19
- Docs (3y) 171
- Cites (3y) 391
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,1
- 5Y JIF 2,1
- JCI 0,43
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q3
- Genetics Q2
- Genetics (clinical) Q2
- Oncology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology | Genetics & Heredity
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,849 | 2,1 | 2,1 | 0,43 | Q3 | 72 |
| 2024 | Q2 | Q3 | 1,018 | 2 | 2,3 | 0,48 | Q3 | 70 |
| 2023 | Q2 | Q3 | 1,016 | 1,8 | 1,9 | 0,41 | Q3 | 70 |
| 2022 | Q2 | Q3 | 1,031 | 2,2 | 2,1 | 0,5 | Q3 | 70 |
| 2021 | Q3 | Q3 | 0,667 | 2,4 | 2,4 | 0,44 | Q3 | 70 |
| 2020 | Q2 | Q3 | 0,946 | 2,4 | 2,5 | 0,52 | Q3 | 70 |
| 2019 | Q2 | Q4 | 0,919 | 1,8 | 1,9 | 0,56 | Q3 | 70 |
| 2018 | — | Q3 | — | 2,2 | 2,1 | 0,56 | Q3 | — |
| 2017 | Q2 | Q3 | 0,963 | 1,9 | 2 | 0,54 | Q3 | 70 |
| 2016 | Q2 | Q3 | 1,015 | 1,7 | 1,9 | — | — | 70 |
| 2015 | Q2 | Q3 | 1,055 | 2,1 | 1,9 | — | — | 70 |
| 2014 | Q2 | Q3 | 1,059 | 2 | 1,8 | — | — | 70 |
| 2013 | Q2 | Q4 | 0,841 | 1,6 | 1,7 | — | — | 70 |
| 2012 | Q2 | Q3 | 0,972 | 1,9 | 1,9 | — | — | 70 |
| 2011 | Q2 | Q4 | 0,901 | 1,3 | 1,6 | — | — | 70 |
| 2010 | Q2 | Q3 | 0,892 | 2,1 | 2,3 | — | — | 70 |
| 2009 | — | Q3 | — | 2,2 | — | — | — | — |
| 2008 | — | Q3 | — | 2,1 | — | — | — | — |
| 2007 | — | Q3 | — | 2,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 125/192 |
| 2025 | ONCOLOGY | SCIE | Q3 | Q3 | 236/333 |
| 2024 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 119/192 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q3 | 233/328 |
| 2023 | GENETICS & HEREDITY | SCIE | Q3 | Q4 | 130/191 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q3 | 241/322 |
| 2022 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 116/171 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q3 | 200/241 |
| 2021 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 126/175 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q3 | 202/245 |
| 2020 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 124/176 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q3 | 214/242 |
| 2019 | GENETICS & HEREDITY | SCIE | Q4 | Q3 | 134/178 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q3 | 215/244 |
| 2018 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 109/174 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q3 | 170/230 |
| 2017 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 115/171 |
| 2017 | ONCOLOGY | SCIE | Q4 | Q3 | 178/223 |
| 2016 | GENETICS & HEREDITY | SCIE | Q3 | — | 120/167 |
| 2016 | ONCOLOGY | SCIE | Q4 | — | 178/217 |
| 2015 | GENETICS & HEREDITY | SCIE | Q3 | — | 105/166 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 151/213 |
| 2014 | GENETICS & HEREDITY | SCIE | Q3 | — | 116/167 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 153/211 |
| 2013 | GENETICS & HEREDITY | SCIE | Q4 | — | 132/165 |
| 2013 | ONCOLOGY | SCIE | Q4 | — | 158/203 |
| 2012 | GENETICS & HEREDITY | SCIE | Q3 | — | 111/161 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 133/197 |
| 2011 | GENETICS & HEREDITY | SCIE | Q4 | — | 127/158 |
| 2011 | ONCOLOGY | SCIE | Q4 | — | 154/196 |
| 2010 | GENETICS & HEREDITY | SCIE | Q3 | — | 99/156 |
| 2010 | ONCOLOGY | SCIE | Q3 | — | 111/185 |
| 2009 | GENETICS & HEREDITY | SCIE | Q3 | — | 88/146 |
| 2009 | ONCOLOGY | SCIE | Q3 | — | 93/166 |
| 2008 | GENETICS & HEREDITY | SCIE | Q3 | — | 89/138 |
| 2008 | ONCOLOGY | SCIE | Q3 | — | 100/143 |
| 2007 | GENETICS & HEREDITY | SCIE | Q3 | — | 82/132 |
| 2007 | ONCOLOGY | SCIE | Q3 | — | 80/132 |